The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under "Note about Forward-Looking Statements" and Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the fiscal year endedFebruary 29, 2020 .
The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.
The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:
? our future operating results and the impact of COVID-19 pandemic thereon;
? the introduction, withdrawal, success and timing of business initiatives and
strategies;
? changes in political, economic or industry conditions, the interest rate
environment or financial and capital markets, which could result in changes in
the value of our assets;
? pandemics or other serious public health events, such as the recent global
outbreak of COVID-19;
? the relative and absolute investment performance and operations of our Manager;
? the impact of increased competition;
? our ability to turn potential investment opportunities into transactions and
thereafter into completed and successful investments;
? the unfavorable resolution of any future legal proceedings;
? our business prospects and the prospects of our portfolio companies, including
our and their ability to achieve our respective objectives as a result of the
current COVID-19 pandemic;
? the impact of investments that we expect to make and future acquisitions and
divestitures;
? our contractual arrangements and relationships with third parties;
? the dependence of our future success on the general economy and its impact on
the industries in which we invest and the impact of the COVID-19 pandemic
thereon;
? the ability of our portfolio companies to achieve their objectives;
? our expected financings and investments;
? our regulatory structure and tax status, including our ability to operate as a
business development company ("BDC"), or to operate our small business
investment company ("SBIC") subsidiaries, and to continue to qualify to be
taxed as a regulated investment company ("RIC");
? the adequacy of our cash resources and working capital;
? the timing of cash flows, if any, from the operations of our portfolio
companies and the impact of the COVID-19 pandemic thereon;
? the impact of interest rate volatility on our results, particularly because we
use leverage as part of our investment strategy;
? the impact of legislative and regulatory actions and reforms and regulatory,
supervisory or enforcement actions of government agencies relating to us or our
Manager;
? the impact of changes to tax legislation and, generally, our tax position;
? our ability to access capital and any future financings by us;
? the ability of our Manager to attract and retain highly talented professionals;
and
? the ability of our Manager to locate suitable investments for us and to monitor
and effectively administer our investments and the impacts of the COVID-19 pandemic thereon. 64 The following statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
? changes in laws and regulations, changes in political, economic or industry
conditions, and changes in the interest rate environment, including with
respect to the anticipated discontinuation of LIBOR, or other conditions
affecting the financial and capital markets, including with respect to changes
resulting from or in response to, or potentially even the absence of changes as
a result of, the impact of the COVID-19 pandemic;
? the length and duration of the COVID-19 outbreak in
as worldwide, and the magnitude of its impact and time required for economic
recovery, including with respect to the impact of travel restrictions and other
isolation and quarantine measures on the ability of the Manager's investment
professionals to conduct in-person diligence on, and otherwise monitor,
existing and future investments;
? an economic downturn and the time period required for robust economic recovery
therefrom, including the current economic downturn as a result of the impact of
the COVID-19 pandemic, which may have a material impact on our portfolio
companies' results of operations and financial condition, which could lead to
the loss of some or all of our investments in certain portfolio companies and
have a material adverse effect on our results of operations and financial
condition;
? a contraction of available credit, an inability or unwillingness of our lenders
to fund their commitments to us and/or an inability to access capital markets
or additional sources of liquidity, including as a result of the impact and
duration of the COVID-19 pandemic, could have a material adverse effect on our
results of operations and financial condition and impair our lending and
investment activities;
? risks associated with possible disruption in our portfolio companies'
operations due to wars and other forms of conflict, terrorist acts, security
operations and catastrophic events such as fires, floods, earthquakes,
tornadoes, hurricanes and global health epidemics; and
? the risks, uncertainties and other factors we identify in "Risk Factors" in our
most recent Annual Report on Form 10-K under Part I, Item 1A, in our quarterly
reports on Form 10-Q, including this report, and in our other filings with the
SEC that we make from time to time. Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "project," "should," "will" and "would" or the negative of these terms or other comparable terminology. We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law orSEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with theSEC , including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on
Form 8-K.
The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this quarterly report on Form 10-Q.
OVERVIEW We are aMaryland corporation that has elected to be treated as a BDC under the 1940 Act. Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by privateU.S. middle market companies, which we define as companies having earnings before interest, tax, depreciation and amortization ("EBITDA") of between$2 million and$50 million , both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of "investment company" under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Code. 65 COVID-19 Update OnMarch 11, 2020 , theWorld Health Organization declared the novel coronavirus, or COVID-19, as a pandemic, and onMarch 13, 2020 the United States declared a national emergency with respect to COVID-19. The outbreak of COVID-19 has severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has been rapidly evolving and many countries, includingthe United States , have reacted by instituting quarantines, restricting travel and hospitality, and temporarily closing or limiting operations at many corporate offices, retail stores, restaurants, fitness clubs and manufacturing facilities and factories in affected jurisdictions. Such actions are creating disruption in global supply chains and adversely impacting a number of industries. The outbreak could have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The rapid development and fluidity of this situation precludes any prediction as to the ultimate adverse impact of COVID-19. Nevertheless, COVID-19 presents material uncertainty and risks with respect to the underlying value of the Company's portfolio companies, the Company's business, financial condition, results of operations and cash flows, such as the potential negative impact to financing arrangements, company decisions to delay, defer and/or modify the character of dividends in order to preserve liquidity, increased costs of operations, changes in law and/or regulation, and uncertainty regarding government and regulatory policy. We have evaluated subsequent events fromDecember 1, 2020 throughJanuary 6, 2021 . However, as the discussion in this Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations relates to the Company's financial statements for the quarter-endedNovember 30, 2020 , the analysis contained herein may not fully account for impacts relating to the COVID-19 pandemic. In that regard, for example, as ofNovember 30, 2020 , the Company valued its portfolio investments in conformity withU.S. GAAP based on the facts and circumstances known by the Company at that time, or reasonably expected to be known at that time. Due to the overall volatility that the COVID-19 pandemic has caused during the months that followed ourNovember 30, 2020 valuation, any valuations conducted now or in the future in conformity withU.S. GAAP could result in a lower fair value of our portfolio. The potential impact to our results going forward will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID- 19 and the actions taken by authorities and other entities to contain the coronavirus or treat its impact, all of which are beyond our control. Accordingly, the Company cannot predict the extent to which its financial condition and results of operations will be affected at this time. Corporate History We commenced operations, at the time known asGSC Investment Corp. , onMarch 23, 2007 and completed an initial public offering of shares of common stock onMarch 28, 2007 . Prior toJuly 30, 2010 , we were externally managed and advised byGSCP (NJ), L.P. , an entity affiliated withGSC Group, Inc. In connection with the consummation of a recapitalization transaction onJuly 30, 2010 , as described below we engagedSaratoga Investment Advisors to replaceGSCP (NJ), L.P. as our investment adviser and changed our name toSaratoga Investment Corp. As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, inDecember 2008 we engaged the investment banking firm ofStifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. OnApril 14, 2010 ,GSC Investment Corp. entered into a stock purchase agreement withSaratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement withSaratoga Investment Advisors , pursuant to whichGSC Investment Corp. assumed certain rights and obligations ofSaratoga Investment Advisors under a debt commitment letterSaratoga Investment Advisors received fromMadison Capital Funding LLC , which indicatedMadison Capital Funding's willingness to provideGSC Investment Corp. with a$40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition,GSC Investment Corp. andGSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to whichGSCP (NJ), L.P. , among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement. OnJuly 30, 2010 , the transactions contemplated by the stock purchase agreement withSaratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for$15.0 million in aggregate purchase price toSaratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business asSaratoga Investment Corp. We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder onJuly 30, 2010 . OnAugust 12, 2010 , we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was$230 . Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding. 66
In
OnMarch 28, 2012 , our wholly-owned subsidiary,Saratoga Investment Corp. SBIC, LP ("SBIC LP "), received an SBIC license from theSmall Business Administration ("SBA"). OnAugust 14, 2019 , our wholly-owned subsidiary,Saratoga Investment Corp. SBIC II LP ("SBIC II LP "), also received an SBIC license from the SBA. InMay 2013 , we issued$48.3 million in aggregate principal amount of our 7.50% fixed-rate unsecured notes due 2020 (the "2020 Notes") for net proceeds of$46.1 million after deducting underwriting commissions of$1.9 million and offering costs of$0.3 million . The proceeds included the underwriters' full exercise of their overallotment option. The 2020 Notes were listed on the NYSE under the trading symbol "SAQ" with a par value of$25.00 per share. The 2020 Notes were redeemed in full onJanuary 13, 2017 and are no longer listed on the NYSE. OnMay 29, 2015 , we entered into a Debt Distribution Agreement withLadenburg Thalmann & Co. through which we may offer for sale, from time to time, up to$20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market ("ATM") offering. Prior to the 2020 Notes being redeemed in full, the Company sold 539,725 bonds with a principal of$13.5 million at an average price of$25.31 for aggregate net proceeds of$13.4 million (net of transaction costs).
OnDecember 21, 2016 , we issued$74.5 million in aggregate principal amount of our 6.75% fixed-rate unsecured notes due 2023 (the "2023Notes") for net proceeds of$71.7 million after deducting underwriting commissions of approximately$2.3 million and offering costs of approximately$0.5 million . The issuance included the exercise of substantially all of the underwriters' option to purchase an additional$9.8 million aggregate principal amount of 2023 Notes within 30 days. The 2023 Notes were listed on the NYSE under the trading symbol "SAB" with a par value of$25.00 per share. OnDecember 21, 2019 andFebruary 7, 2020 , the Company redeemed$50.0 million and$24.5 million , respectively, in aggregate principal amount of the$74.5 million in aggregate principal amount of issued and outstanding 2023 Notes. OnMarch 16, 2017 , we entered into an equity distribution agreement withLadenburg Thalmann & Co. Inc. , through which we may offer for sale, from time to time, up to$30.0 million of our common stock through an ATM offering. Subsequent to this,BB&T Capital Markets andB. Riley FBR, Inc. were also added to the agreement. OnJuly 11, 2019 , the amount of the common stock to be offered through this offering was increased to$70.0 million , and onOctober 8, 2019 , the amount of the common stock to be offered was increased to$130.0 million . As ofNovember 30, 2020 , the Company sold 3,922,018 shares for gross proceeds of$97.1 million at an average price of$24.77 for aggregate net proceeds of$95.9 million (net of transaction costs). During the nine months endedNovember 30, 2020 , there was no activity related to the ATM offering. OnJuly 13, 2018 , the Company issued 1,150,000 shares of its common stock priced at$25.00 per share (par value$0.001 per share) at an aggregate total of$28.75 million . The net proceeds, after deducting underwriting commissions of$1.15 million and offering costs of approximately$0.2 million , amounted to approximately$27.4 million . The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock,
which was not exercised.
OnAugust 28, 2018 , the Company issued$40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the "6.25% 2025 Notes") for net proceeds of$38.7 million after deducting underwriting commissions of approximately$1.3 million . Offering costs incurred were approximately$0.3 million . The issuance included the full exercise of the underwriters' option to purchase an additional$5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 6.25% per year, beginningNovember 30, 2018 . The 6.25% 2025 Notes mature onAugust 31, 2025 and commencingAugust 28, 2021 , may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. OnDecember 14, 2018 , the Company completed the third refinancing of the Saratoga CLO (the "2013-1 Reset CLO Notes"). This refinancing, among other things, extended the Saratoga CLO reinvestment period toJanuary 2021 , and extended its legal maturity toJanuary 2030 . A non-call period ofJanuary 2020 was also added. In addition to and as part of the refinancing, the Saratoga CLO has also been upsized from$300 million in assets to approximately$500 million . As part of this refinancing and upsizing, the Company invested an additional$13.8 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased$2.5 million in aggregate principal amount of the Class F-R-2 Notes tranche and$7.5 million in aggregate principal amount of the Class G-R-2 Notes tranche at par. Concurrently, the existing$4.5 million of Class F notes were repaid. 67 OnFebruary 5, 2019 , the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional$20.0 million in aggregate principal amount for net proceeds of$19.2 million after deducting underwriting commissions of approximately$0.6 million and discount of$0.2 million . Offering costs incurred were approximately$0.2 million . The issuance included the full exercise of the underwriters' option to purchase an additional$2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued inAugust 2018 . The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of$1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. As ofNovember 30, 2020 , the total 6.25% 2025 Notes outstanding was$60.0 million . The 6.25% 2025 Notes are listed on the NYSE under the trading symbol "SAF" with a par value of$25.00 per share. OnAugust 14, 2019 , our wholly-owned subsidiary,Saratoga Investment Corp. SBIC II LP ("SBIC II LP "), also received an SBIC license from the SBA. The new license will provide up to$175.0 million in additional long-term capital in the form of SBA debentures.
OnFebruary 11, 2020 , the Company entered into an unsecured loan agreement withSaratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd., a wholly-owned subsidiary ofSaratoga Investment Corp. CLO 2013-1, Ltd. Pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to$20.0 million from the Company in order to provide capital necessary to support warehouse activities. OnOctober 23, 2020 , the CLO 2013-1 Warehouse 2 Loan was increased to$25.0 million availability, which was immediately fully drawn and, which expires onAugust 20, 2021 . The interest rate was also amended to be based on a pricing grid, starting at an annual rate of3M USD LIBOR + 4.46%. As ofNovember 30, 2020 , the Company's investment in the CLO 2013-1 Warehouse 2 had a fair value of$24.8 million . OnJune 24, 2020 , the Company issued$37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the "7.25% 2025 Notes") for net proceeds of$36.3 million after deducting underwriting commissions of approximately$1.2 million . Offering costs incurred were approximately$0.3 million . OnJuly 6, 2020 , the underwriters exercised their option in full to purchase an additional$5.625 million in aggregate principal amount of its 7.25% unsecured notes due 2025. Net proceeds to the Company were$5.4 million after deducting underwriting commissions of approximately$0.2 million . Interest on the 7.25% 2025 Notes is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 7.25% per year, beginningAugust 31, 2020 . The 7.25% 2025 Notes mature onJune 30, 2025 and commencingJune 24, 2022 , may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes. The Company has received an investment grade private rating of "BBB" fromEgan-Jones Ratings Company , an independent, unaffiliated rating agency. As ofNovember 30, 2020 , the total 7.25% 2025 Notes outstanding was$43.1 million . The 7.25% 2025 Notes are listed on the NYSE under the trading symbol "SAK" with a par value of$25.00 per share. OnJuly 9, 2020 , the Company issued$5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the "7.75% 2025 Notes") for net proceeds of$4.8 million after deducting underwriting commissions of approximately$0.2 million . Offering costs incurred were approximately$0.1 million . Interest on the 7.75% Notes 2025 is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 7.75% per year, beginningAugust 31, 2020 . The 7.75% Notes 2025 mature onJuly 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. As ofNovember 30, 2020 , the total 7.25% 2025 Notes outstanding was$5.0 million . The 7.75% 2025 Notes are unlisted and has a par value of
$25.00 per share. Critical Accounting Policies Basis of Presentation The preparation of financial statements in accordance withU.S. generally accepted accounting principles ("U.S. GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the Company's consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows. Investment Valuation The Company accounts for its investments at fair value in accordance with theFinancial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurement and Disclosures ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact. 68 Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input fromSaratoga Investment Advisors , the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company's ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.
We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:
? Each investment is initially valued by the responsible investment professionals
of
documented and discussed with our senior management; and
? An independent valuation firm engaged by our board of directors independently
reviews a selection of these preliminary valuations each quarter so that the
valuation of each investment for which market quotes are not readily available
is reviewed by the independent valuation firm at least once each fiscal year.
We use a third-party independent valuation firm to value our investment in the
subordinated notes of Saratoga CLO and the Class F-R-2 Notes and Class G-R-2
Notes tranches of the Saratoga CLOs every quarter.
In addition, all our investments are subject to the following valuation process:
? The audit committee of our board of directors reviews and approves each
preliminary valuation and
valuation firm (if applicable) will supplement the preliminary valuation to
reflect any comments provided by the audit committee; and
? Our board of directors discusses the valuations and approves the fair value of
each investment, in good faith, based on the input of
Advisors, independent valuation firm (to the extent applicable) and the audit
committee of our board of directors.
Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined bySaratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO. Revenue Recognition Income Recognition Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments. Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management's judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management's judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. Payment-in-Kind Interest The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind ("PIK") interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest
when due. 69 Revenues
We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis. OnJanuary 22, 2008 , we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced inOctober 2013 with its reinvestment period extended toOctober 2016 . OnNovember 15, 2016 , we completed a second refinancing of the Saratoga CLO with its reinvestment period extended toOctober 2018 . OnDecember 14, 2018 , we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period toJanuary 2021 , and extended its legal maturity date toJanuary 2030 . A non-call period ofJanuary 2020 was also added. Following this refinancing, the Saratoga CLO portfolio increased from approximately$300.0 million in aggregate principal amount to approximately$500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional$13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased$2.5 million in aggregate principal amount of the Class F-R-2 and$7.5 million in aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of LIBOR plus 8.75% and LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing$4.5 million aggregate amount of the Class F notes tranche at par. OnFebruary 11, 2020 , the Company entered into an unsecured loan agreement ("CLO 2013-1 Warehouse 2 Loan") withSaratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. ("CLO 2013-1 Warehouse 2"), a wholly-owned subsidiary ofSaratoga Investment Corp. CLO 2013-1, Ltd. ("Saratoga CLO"), pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to$20.0 million from the Company in order to provide capital necessary to support warehouse activities. OnOctober 23, 2020 , the CLO 2013-1 Warehouse 2 Loan was increased to$25.0 million availability, which was immediately fully drawn and, which expires onAugust 20, 2021 . The interest rate was also amended to be based on a pricing grid, starting at an annual rate of3M USD LIBOR + 4.46%. As ofNovember 30, 2020 , the Company's investment in the CLO 2013-1 Warehouse 2 had a fair value of$24.8 million .
The Saratoga CLO remains effectively 100% owned and managed by
Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes onDecember 14, 2018 , we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%. Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets ("ASC 325-40"), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed. Expenses Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator's overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to: ? organization;
? calculating our net asset value (including the cost and expenses of any
independent valuation firm);
70
? expenses incurred by our Manager payable to third parties, including agents,
consultants or other advisers, in monitoring our financial and legal affairs
and in monitoring our investments and performing due diligence on our
prospective portfolio companies;
? expenses incurred by our Manager payable for travel and due diligence on our
prospective portfolio companies;
? interest payable on debt, if any, incurred to finance our investments;
? offerings of our common stock and other securities;
? investment advisory and management fees;
? fees payable to third parties, including agents, consultants or other advisers,
relating to, or associated with, evaluating and making investments;
? transfer agent and custodial fees;
? federal and state registration fees;
? all costs of registration and listing our common stock on any securities
exchange;
? federal, state and local taxes;
? independent directors' fees and expenses;
? costs of preparing and filing reports or other documents required by
governmental bodies (including the
("SEC") and the SBA);
? costs of any reports, proxy statements or other notices to common stockholders
including printing costs;
? our fidelity bond, directors and officers errors and omissions liability
insurance, and any other insurance premiums;
? direct costs and expenses of administration, including printing, mailing, long
distance telephone, copying, secretarial and other staff, independent auditors
and outside legal costs; and
? administration fees and all other expenses incurred by us or, if applicable,
the administrator in connection with administering our business (including
payments under the Administration Agreement based upon our allocable portion of
the administrator's overhead in performing its obligations under an
Administration Agreement, including rent and the allocable portion of the cost
of our officers and their respective staffs (including travel expenses)).
Pursuant to the investment advisory and management agreement that we had withGSCP (NJ), L.P. , our former investment adviser and administrator, we had agreed to payGSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.
The incentive fee had two parts:
? A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee
net investment income, expressed as a rate of return on the value of the net
assets at the end of the immediately preceding quarter, that exceeded a 1.875%
quarterly hurdle rate measured as of the end of each fiscal quarter. Under this
provision, in any fiscal quarter, our former investment adviser received no
incentive fee unless our pre-incentive fee net investment income exceeded the
hurdle rate of 1.875%. Amounts received as a return of capital were not
included in calculating this portion of the incentive fee. Since the hurdle
rate was based on net assets, a return of less than the hurdle rate on total
assets could still have resulted in an incentive fee.
? A fee, payable at the end of each fiscal year, equal to 20.0% of our net
realized capital gains, if any, computed net of all realized capital losses and
unrealized capital depreciation, in each case on a cumulative basis on each
investment in the Company's portfolio, less the aggregate amount of capital
gains incentive fees paid to our former investment adviser through such date.
71 We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period endedAugust 31, 2007 and continued to defer such payments through the quarterly period endedMay 31, 2010 . As ofJuly 30, 2010 , the date on whichGSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owedGSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which$0.3 million has been paid by us.GSCP (NJ), L.P. agreed to waive payment by us of the remaining$2.6 million in connection with the consummation of the stock purchase transaction withSaratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report. The terms of the investment advisory and management agreement withSaratoga Investment Advisors , our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into withGSCP (NJ), L.P. , our former investment adviser, except for the following material distinctions in the fee terms:
? The capital gains portion of the incentive fee was reset with respect to gains
and losses from
such time will not be taken into account when calculating the capital gains fee
payable to
Advisors will be entitled to 20.0% of net gains that arise after
In addition, the cost basis for computing realized gains and losses on
investments held by us as of
investment as of such date. Under the investment advisory and management
agreement with our former investment adviser,
gains fee was calculated from
outweighed by losses.
? Under the "catch up" provision, 100.0% of our pre-incentive fee net investment
income with respect to that portion of such pre-incentive fee net investment
income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal
quarter is payable to
amount approaches 2.344% in any quarter, and
receive 20.0% of any additional net investment income. Under the investment
advisory and management agreement with our former investment adviser, GSCP
(NJ)
? We will no longer have deferral rights regarding incentive fees in the event
that the distributions to stockholders and change in net assets is less than
7.5% for the preceding four fiscal quarters. Capital Gains Incentive Fee The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company's Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.
New Accounting Pronouncements
InMarch 2020 , the FASB issued ASU 2020-04, Reference Rate Reform ("ASU 2020-04"). The amendments in ASU 2020-04 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The standard is effective as ofMarch 12, 2020 throughDecember 31, 2022 . Management does not believe this optional guidance has a material impact on the Company's consolidated financial statements and disclosures. SEC Rule 12b-2 Update
InMarch 2020 , theSEC adopted a final rule under SEC Release No. 34-88365 (the "Final Rule"), amending the accelerated filer and large accelerated filer definitions in Exchange Act Rule 12b-2. The amendments include a provision under which a BDC will be excluded from the "accelerated filer" and "large accelerated filer" definitions if the BDC has (1) a public float of$75 million or more, but less than$700 million , and (2) has annual investment income of less than$100 million . In addition, BDCs are subject to the same transition provisions for accelerated filer and large accelerated filer status as other issuers, but instead substituting investment income for revenue. The amendments will reduce the number of issuers required to comply with the auditor attestation on the internal control over financial reporting requirement provided under Section 404(b) of the Sarbanes-Oxley Act of 2002. The Final Rule applies to annual report filings due on or afterApril 27, 2020 . The Company has assessed the Final Rule, and believes that effectiveFebruary 28, 2021 , it will no longer be an accelerated filer. As a result, the Company will file its Annual Report on Form 10-K for the fiscal year endingFebruary 28, 2021 as a non-accelerated
filer. 72
Portfolio and Investment Activity
Investment Portfolio Overview November 30, February 29, 2020 2020 ($ in millions) Number of investments(1) 83 74 Number of portfolio companies(2) 42 35 Average investment per portfolio company(2)$ 11.7 $ 12.9 Average investment size(1) $ 6.3 $ 6.3 Weighted average maturity(3) 2.6 yrs 3.1 yrs Number of industries 32 28
Non-performing or delinquent investments (fair value) $ 6.2 $ 2.1 Fixed rate debt (% of interest earning portfolio)(3)
$ 31.3 (6.3 )%$ 29.7 (6.8 )% Fixed rate debt (weighted average current coupon)(3) 8.8 % 9.3 %
Floating rate debt (% of interest earning portfolio)(3)
7.5 % 8.0 %
(1) Excludes our investment in the subordinated notes of Saratoga CLO.
(2) Excludes our investment in the subordinated notes of Saratoga CLO, Class
F-R-2 Notes and Class G-R-2 Notes tranches of Saratoga CLO and loan to
(3) Excludes our investment in the subordinated notes of Saratoga CLO and equity
interests.
(4) Calculation uses either 1-month or 3-month LIBOR, depending on the
contractual terms, and after factoring in any existing LIBOR floors.
During the three months endedNovember 30, 2020 , we invested$51.3 million in new or existing portfolio companies and had$18.3 million in aggregate amount of exits and repayments resulting in net investments of$33.0 million for the period. During the three months endedNovember 30, 2019 , we invested$40.8 million in new or existing portfolio companies and had$51.2 million in aggregate amount of exits and repayments resulting in net exits and repayments of$10.4 million for the period. During the nine months endedNovember 30, 2020 , we invested$122.0 million in new or existing portfolio companies and had$50.9 million in aggregate amount of exits and repayments resulting in net investments of$71.1 million for the period. During the nine months endedNovember 30, 2019 , we invested$160.7 million in new or existing portfolio companies and had$97.2 million in aggregate amount of exits and repayments resulting in net investments of$63.5 million for the period. 73 Portfolio Composition Our portfolio composition atNovember 30, 2020 andFebruary 29, 2020 at fair value was as follows: November 30, 2020 February 29, 2020 Weighted Weighted Percentage Average Percentage Average of Total Current of Total Current Portfolio Yield Portfolio Yield
First lien term loans 74.5 % 9.5 % 71.3 % 9.6 % Second lien term loans 9.2 11.5 15.1 10.7 Unsecured term loans 4.9 4.4 0.9 9.3
Structured finance securities 5.7 17.6
6.7 11.4 Equity interests 5.7 - 6.0 - Total 100.0 % 9.4 % 100.0 % 9.3 %
AtNovember 30, 2020 , our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of$21.6 million and constituted 3.9% of our portfolio. This investment constitutes a first loss position in a portfolio that, as ofNovember 30, 2020 andFebruary 29, 2020 , was composed of$540.0 million and$528.4 million , respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as ofNovember 30, 2020 , we also own$2.5 million in aggregate principal of the F-R-2 Notes and$7.5 million in aggregate principal of the G-R-2 Notes in the Saratoga CLO, that only rank senior to the subordinated notes. AtNovember 30, 2020 , our investment in CLO 2013-1 Warehouse 2, a wholly-owned subsidiary of Saratoga CLO, had a fair value of$24.8 million and constituted 4.5% of our portfolio. This investment is subject to unique risks. (See "Part 1. Item 1A. Risk Factors-Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility" in our Annual Report on Form 10-K for the fiscal year endedFebruary 29, 2020 ). We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, atNovember 30, 2020 ,$512.7 million or 99.2% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and five Saratoga CLO portfolio investments were in default with a fair value of$1.7 million . AtFebruary 29, 2020 ,$494.2 million or 98.6% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of$1.4 million . For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year endedFebruary 29, 2020 .
74 Portfolio CMR distribution
The CMR distribution for our investments at
Saratoga Investment Corp. November 30, 2020 February 29, 2020 Investments Percentage Investments Percentage at of Total at of Total Color Score Fair Value Portfolio Fair Value Portfolio ($ in thousands) Green$ 458,469 83.8 %$ 429,784 88.5 % Yellow 35,836 6.6 2,141 0.5 Red - 0.0 2,137 0.4 N/A(1) 52,639 9.6 51,570 10.6 Total$ 546,944 100.0 %$ 485,632 100.0 %
(1) Comprised of our investment in the subordinated notes of Saratoga CLO and
equity interests.
The change in reserve from
The CMR distribution of Saratoga CLO investments at
Saratoga CLONovember 30, 2020 February 29, 2020
Investments Percentage Investments Percentage at of Total at of Total Color Score Fair Value Portfolio Fair Value Portfolio ($ in thousands) Green$ 439,472 85.0 %$ 456,767 91.1 % Yellow 73,185 14.2 37,446 7.5 Red 3,912 0.8 6,787 1.4 N/A(1) 145 0.0 0 0.0 Total$ 516,714 100.0 %$ 501,000 100.0 %
(1) Comprised of Saratoga CLO's equity interests.
75 Portfolio composition by industry grouping at fair value
The following table shows our portfolio composition by industry grouping at fair
value at
Saratoga Investment Corp. November 30, 2020 February 29, 2020* Investments Percentage Investments Percentage At of Total At of Total Fair Value Portfolio Fair Value Portfolio ($ in thousands) Education Software$ 84,613 15.5 %$ 96,055 19.8 % IT Services 81,556 14.9 62,541 12.9 Structured Finance Securities(1) 56,131 10.3
34,675 7.1 Education Services 32,358 5.9 36,365 7.5 Healthcare Services 30,468 5.4 28,455 5.9 Healthcare Software 28,910 5.3 30,764 6.3 Sports Management 24,521 4.5 25,740 5.3
Dental Practice Management Software 22,931 4.2
- 0.0 Payroll Services 19,089 3.5 19,055 3.9 Marketing Services 17,200 3.1 14,200 2.9 Hospitality/Hotel 15,088 2.8 14,894 3.1 Real Estate Services 14,859 2.7 - 0.0
Construction Management Services 14,135 2.6
4,284 0.9 Property Management 12,973 2.4 11,503 2.4 Cyber Security 12,868 2.4 9,982 2.1 Corporate Governance 9,522 1.7 9,090 1.9 Industrial Products 9,502 1.7 10,779 2.2 Waste Services 8,969 1.6 9,000 1.9
Healthcare Products Manufacturing 8,153 1.5
7,717 1.6 HVAC Services and Sales 6,930 1.3 - 0.0 Facililties Maintenance 6,538 1.2 5,375 1.1 Dental Practice Management 6,489 1.2 - 0.0 Non-profit Services 5,525 1.0 5,555 1.1 Healthcare Supply 4,338 0.8 2,137 0.4 Field Service Management 3,952 0.7 2,970 0.6 Office Supplies 3,527 0.6 3,799 0.8 Metals 1,998 0.4 3,130 0.6 Restaurant 1,985 0.4 2,140 0.4 Staffing Services 693 0.1 922 0.2 Financial Services 425 0.1 32,090 6.6 Consumer Products 392 0.1 418 0.1 Consumer Services 306 0.1 1,997 0.4 Total$ 546,944 100.0 %
$ 485,632 100.0 %
* Certain reclassifications have been made to previously reported industry
groupings to show results on a consistent basis across periods.
(1) Comprised of our investment in the subordinated notes, Class F-R-2 Notes and
Class G-R-2 Notes ofSaratoga CLO and Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. 76
The following table shows Saratoga CLO's portfolio composition by industry
grouping at fair value at
Saratoga CLO November 30, 2020 February 29, 2020 Investments Percentage Investments Percentage at of Total at of Total Fair Value Portfolio Fair Value Portfolio ($ in
thousands)
Banking Finance Insurance & Real Estate$ 96,062 18.6 %$ 87,957 17.6 % Services: Business 44,988 8.7 45,735 9.1 Healthcare & Pharmaceuticals 38,770 7.5
39,978 8.0 High Tech Industries 38,413 7.4 32,897 6.6 Telecommunications 29,327 5.8 28,317 5.6 Services: Consumer 24,105 4.7 28,327 5.6 Aerospace & Defense 23,741 4.6 25,093 5.0
Media: Advertising Printing & Publishing 21,752 4.2 19,808 4.0 Chemicals Plastics & Rubber 18,945 3.7 14,689 2.9 Beverage Food & Tobacco 17,512 3.4 21,637 4.3 Consumer goods: Non-durable 17,694 3.4
15,700 3.1 Hotel Gaming & Leisure 17,024 3.3 16,883 3.4 Automotive 14,997 2.9 13,820 2.8
Containers Packaging & Glass 12,467 2.4 15,753 3.1 Media: Broadcasting & Subscription 12,573 2.4
7,959 1.6 Retail 11,901 2.3 14,538 2.9 Capital Equipment 10,784 2.1 9,551 1.9 Consumer goods: Durable 8,383 1.6 11,674 2.3 Utilities: Oil & Gas 7,952 1.5 7,306 1.5 Transportation: Cargo 7,095 1.4 7,054 1.4 Forest Products & Paper 7,375 1.4 5,385 1.1 Metals & Mining 7,352 1.4 4,112 0.8 Transportation: Consumer 6,148 1.2 1,914 0.4 Construction & Building 4,393 0.9 7,617 1.5 Utilities: Electric 4,262 0.8 4,752 1.0
Media: Diversified & Production 3,058 0.6
2,711 0.5 Wholesale 2,833 0.5 1,928 0.4 Energy: Oil & Gas 2,135 0.4 3,559 0.7 Energy: Electricity 1,990 0.4 3,357 0.7 Utilities 1,708 0.3 - 0.0 Environmental Industries 975 0.2 989 0.2 Total$ 516,714 100.0 %$ 501,000 100.0 % 77 Portfolio composition by geographic location at fair value The following table shows our portfolio composition by geographic location at fair value atNovember 30, 2020 andFebruary 29, 2020 . The geographic composition is determined by the location of the corporate headquarters of the portfolio company. November 30, 2020 February 29, 2020 Investments Percentage Investments Percentage at of Total at of Total Fair Value Portfolio Fair Value Portfolio ($ in thousands) Southeast$ 170,188 31.1 %$ 165,353 34.0 % West 130,903 23.9 99,390 20.5 Midwest 101,415 18.5 75,528 15.5 Other 76,867 14.1 55,877 11.5 Northeast 22,968 4.2 18,047 3.7 Northwest 12,868 2.4 9,981 2.1 Southwest(1) 31,735 5.8 61,456 12.7 Total$ 546,944 100.0 %$ 485,632 100.0 %
(1) Comprised of our investment in the subordinated notes, Class F-R-2 Notes and
Class G-R-2 Notes of Saratoga CLO,
Warehouse 2, Ltd and foreign investments. Results of operations
Operating results for the three and nine months ended
For the three months ended For the nine months ended November 30, November 30, November 30, November 30, 2020 2019 2020 2019 ($ in thousands) Total investment income$ 14,283 $ 14,196 $ 41,435 $ 40,835 Total operating expenses 9,812 9,621 22,611 27,623 Net investment income 4,471 4,575 18,824 13,212 Net realized gain (loss) from investments 2 10,740 22 12,610 Income tax (provision) benefit from realized gain on investments (3,895 ) - (3,895 ) - Net change in unrealized appreciation (depreciation) on investments 5,999 (536 ) (9,371 ) 4,911 Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments (210 ) (1,062 ) (59 ) (1,787 ) Net increase (decrease) in net assets resulting from operations$ 6,367 $ 13,717 $ 5,521 $ 28,946 78 Investment income
The composition of our investment income for three and nine months ended
For the three months ended For the nine months ended November 30, November 30, November 30, November 30, 2020 2019 2020 2019 ($ in thousands) Interest from investments$ 12,804 $ 12,899 $ 37,215 $ 36,244 Interest from cash and cash equivalents 1 120 14 317 Management fee income 624 630 1,884 1,889 Structuring and advisory fee income* 545 511 1,798 1,875 Other income* 309 36 524 510 Total investment income$ 14,283 $ 14,196 $ 41,435 $ 40,835
* Certain prior period amounts have been reclassified to conform to current
period presentation. For the three months endedNovember 30, 2020 , total investment income increased$0.1 million , or 0.6% to$14.3 million from$14.2 million for the three months endedNovember 30, 2019 . Interest income from investments decreased$0.1 million , or 0.7%, to$12.8 million for the three months endedNovember 30, 2020 from$12.9 million for the three months endedNovember 30, 2019 . This reflects the impact of the increase of$59.9 million , or 12.3% in total investments atNovember 30, 2020 from$487.0 million atNovember 30, 2019 , offset by the reduction in LIBOR during this same period. AtNovember 30, 2020 , the weighted average current yield on investments was 9.4% compared to 9.8% atNovember 30, 2019 , which offset most of the increase in investments. For the nine months endedNovember 30, 2020 , total investment income increased$0.6 million , or 1.5% to$41.4 million from$40.8 million for the nine months endedNovember 30, 2019 . Interest income from investments increased$1.0 million , or 2.7%, to$37.2 million for the nine months endedNovember 30, 2020 from$36.2 million for the nine months endedNovember 30, 2019 . This reflects the partial period impact of the increase of$59.9 million , or 12.3% in total investments atNovember 30, 2020 from$487.0 million atNovember 30, 2019 , offset by the reduction in LIBOR during the same period. For the three months endedNovember 30, 2020 andNovember 30, 2019 , total PIK income was$0.3 million and$1.5 million , respectively. For the nine months endedNovember 30, 2020 andNovember 30, 2019 , total PIK income was$1.4 million and$3.9 million , respectively. This decrease was primarily due to the sale of our investment inEasy Ice, LLC during the fourth quarter of the fiscal year endedFebruary 29, 2020 , which primarily generated PIK income. Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months endedNovember 30, 2020 andNovember 30, 2019 , total management fee income was$0.6 million and$0.6 million , respectively. For the nine months endedNovember 30, 2020 andNovember 30, 2019 , total management fee income was$1.9 million and$1.9 million , respectively. 79 Operating expenses
The composition of our operating expenses for the three and nine months ended
For the three months ended For the nine months ended November 30, November 30, November 30, November 30, 2020 2019 2020 2019 ($ in thousands) Interest and debt financing expenses$ 3,560 $ 3,897 $ 9,452 $ 11,628 Base management fees 2,324 2,147 6,694 5,956 Incentive management fees expense (benefit) 2,295
3,102 1,966 7,301 Professional fees 503 401 1,258 1,181 Administrator expenses 694 556 1,852 1,575 Insurance 67 64 203 193 Directors fees and expenses 60 60 195 218
General & administrative and other expenses 279 395 963 1,036 Income tax expense (benefit) 30 (1,001 ) 28 (1,465 ) Total operating expenses$ 9,812 $ 9,621 $ 22,611 $ 27,623 For the three months endedNovember 30, 2020 , total operating expenses increased$0.2 million , or 2.0% compared to the three months endedNovember 30, 2019 . For the nine months endedNovember 30, 2020 , total operating expenses decreased$5.0 million , or 18.1% compared to the nine months endedNovember 30, 2019 . For the three months endedNovember 30, 2020 , interest and debt financing expenses decreased$0.3 million , or 8.7% compared to the three months endedNovember 30, 2019 . The decrease is primarily attributable to a decrease in average outstanding debt from$286.6 million for the three months endedNovember 30, 2019 to$278.4 million for the three months endedNovember 30, 2020 , primarily reflecting the redemption of our 2023 Notes during the fiscal quarter endedFebruary 29, 2020 . For the nine months endedNovember 30, 2020 , interest and debt financing expenses decreased$2.2 million , or 18.7% compared to the nine months endedNovember 30, 2019 . The decrease is primarily attributable to a decrease in average outstanding debt from$284.6 million for the nine months endedNovember 30, 2019 to$253.6 million for the nine months endedNovember 30, 2020 , primarily reflecting the redemption of our 2023 Notes during the fiscal quarter endedFebruary 29, 2020 .
For the three months endedNovember 30, 2020 , the weighted average interest rate on our outstanding indebtedness was 4.42% compared to 4.79% for the three months endedNovember 30, 2019 . The decrease in weighted average interest rate was primarily driven by the redemption of the 2023 Notes during the fiscal quarter endedFebruary 29, 2020 which carried a fixed rate of 6.75%. For the nine months endedNovember 30, 2020 , the weighted average interest rate on our outstanding indebtedness was 6.41% compared to 4.81% for the nine months endedNovember 30, 2019 . The decrease in weighted average interest rate was primarily driven by the redemption of the 2023 Notes during the fiscal quarter endedFebruary 29, 2020 which carried a fixed rate of 6.75%.
As of
For the three months endedNovember 30, 2020 , base management fees increased$0.2 million , or 8.3% from$2.1 million to$2.3 million compared to the three months endedNovember 30, 2019 . The increase in base management fees results from the 8.0% increase in the average value of our total assets, less cash and cash equivalents, from$493.3 million for the three months endedNovember 30, 2019 to$532.8 million for the three months endedNovember 30, 2020 . For the nine months endedNovember 30, 2020 , base management fees increased$0.7 million , or 12.4% from$6.0 million to$6.7 million compared to the nine months endedNovember 30, 2019 . The increase in base management fees results from the 12.1% increase in the average value of our total assets, less cash and cash equivalents, from$452.9 million for the nine months endedNovember 30, 2019 to$507.7 million for the nine months endedNovember 30, 2020 . For the three months endedNovember 30, 2020 , incentive management fees decreased$0.8 million , or 26.0%, compared to the three months endedNovember 30, 2019 . The first part of the incentive management fees decreased from$1.5 million for the three months endedNovember 30, 2019 to$1.2 million for the three months endedNovember 30, 2020 , as net equity increased by 32.9% during this period resulting in an increase to the net investment income hurdle rate pursuant to the Management Agreement. The incentive management fees related to capital gains decreased from a$1.6 million expense for the three months endedNovember 30, 2019 to a$1.1 million expense for the three months endedNovember 30, 2020 , with the incentive fee expense on unrealized gains on the Company'sCensis and Easy Ice investments last year offsetting the incentive fee expense on this quarter's unrealized appreciation across numerous investments. 80 For the nine months endedNovember 30, 2020 , incentive management fees decreased$5.3 million , or 73.1%, compared to the nine months endedNovember 30, 2019 . The first part of the incentive management fees decreased from$4.1 million for the nine months endedNovember 30, 2019 to$4.0 million for the nine months endedNovember 30, 2020 , as higher average net equity during this period resulted in an increase to the net investment income hurdle rate pursuant to the Management Agreement. The incentive management fees related to capital gains decreased from a$3.2 million expense for the nine months endedNovember 30, 2019 to a$(2.0) million benefit for the nine months endedNovember 30, 2020 , reflecting a reversal of incentive fee accrual due to an increase in unrealized depreciation on investments during the nine months endedNovember 30, 2020 .
For the three and nine months ended
For the three and nine months endedNovember 30, 2020 , administrator expenses increased$0.1 million , or 24.7%, and increased$0.3 million , or 17.6%, respectively, compared to the three and nine months endedNovember 30, 2019 . These increases during the period are primarily attributable to an increase to the cap on the payment or reimbursements of expenses by the Company from$2.0 million to$2.225 million , effectiveAugust 1, 2019 , and from$2.225 million to$2.775 million , effectiveAugust 1, 2020 . As discussed above, the decrease in interest and debt financing expenses for the three months endedNovember 30, 2020 compared to the three months endedNovember 30, 2019 is primarily attributable to a decrease in the average dollar amount of outstanding debt. During the three months endedNovember 30, 2020 andNovember 30, 2019 , the average borrowings outstanding under the Credit Facility was$0.0 million and$2.1 million , respectively. For the three months endedNovember 30, 2020 andNovember 30, 2019 , the average borrowings outstanding of SBA debentures was$170.3 million and$150.0 million , respectively. For the three months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average interest rate on the outstanding borrowings of the SBA debentures was 2.97% and 3.21%, respectively. During the three months endedNovember 30, 2020 andNovember 30, 2019 , the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was$60.0 million and$60.0 million , respectively. During the three months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was$43.1 million and$0.0 million , respectively. During the three months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was$5.0 million and$0.0 million , respectively. During the three months endedNovember 30, 2020 andNovember 30, 2019 , the average dollar amount of our 6.75% fixed-rate 2023 Notes outstanding was$0.0 million and$74.5 million , respectively. As discussed above, the decrease in interest and debt financing expenses for the nine months endedNovember 30, 2020 compared to the nine months endedNovember 30, 2019 is primarily attributable to a decrease in the average dollar amount of outstanding debt. During the nine months endedNovember 30, 2020 andNovember 30, 2019 , the average borrowings outstanding under the Credit Facility was$0.0 million and$0.8 million , respectively. For the nine months endedNovember 30, 2020 andNovember 30, 2019 , the average borrowings outstanding of SBA debentures was$165.9 million and$150.0 million , respectively. For the nine months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average interest rate on the outstanding borrowings of the SBA debentures was 4.57% and 3.24%, respectively. During the nine months endedNovember 30, 2020 andNovember 30, 2019 , the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was$60.0 million and$60.0 million , respectively. During the nine months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was$43.1 million and$0.0 million , respectively. During the nine months endedNovember 30, 2020 andNovember 30, 2019 , the weighted average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was$5.0 million and$0.0 million , respectively. During the nine months endedNovember 30, 2020 andNovember 30, 2019 , the average dollar amount of our 6.75% fixed-rate 2023 Notes outstanding was$0.0 million and$74.5 million , respectively. For the three months endedNovember 30, 2020 andNovember 30, 2019 , there were income tax expense (benefits) of$0.03 million and$1.0 million , respectively. For the nine months endedNovember 30, 2020 andNovember 30, 2019 , there were income tax expense (benefits) of$0.03 million and$1.5 million , respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in the taxable blockers.
Net realized gains (losses) on sales of investments
For the three months endedNovember 30, 2020 , the Company had$18.3 million of sales, repayments, exits or restructurings resulting in$0.0 million of net realized gains. For the nine months endedNovember 30, 2020 , the Company had$50.9 million of sales, repayments, exits or restructurings resulting in$0.02 million of net realized gains. In addition, for the three and nine months endedNovember 30, 2020 , the Company recognized an income tax expense of$3.9 million representing federal tax paid on the Company's undistributed net realized capital gains as ofFebruary 29, 2020 . 81
For the three months endedNovember 30, 2019 , the Company had$51.2 million of sales, repayments, exits or restructurings resulting in$10.7 million of net realized gains. For the nine months endedNovember 30, 2019 , the Company had$97.2 million of sales, repayments, exits or restructurings resulting in$12.6 million of net realized gains. The most significant realized gains and losses during the nine months endedNovember 30, 2019 were as follows (dollars in thousands): Nine Months ended November 30, 2019 Net Realized Issuer Asset Type Gross Proceeds Cost Gain Censis Technologies, Inc. Equity Interests$ 12,280 $ 999 $ 11,281 First Lien Term Loan & Fancy Chap, Inc. Equity Interests 8,175 6,865 1,310
Net change in unrealized appreciation (depreciation) on investments
For the three months endedNovember 30, 2020 , our investments had a net change in unrealized appreciation of$6.0 million versus a net change in unrealized depreciation of$0.5 million for the three months endedNovember 30, 2019 . For the nine months endedNovember 30, 2020 , our investments had a net change in unrealized depreciation of$9.4 million versus a net change in unrealized appreciation of$4.9 million for the nine months endedNovember 30, 2019 . The most significant cumulative net change in unrealized appreciation (depreciation) for the nine months endedNovember 30, 2020 were the following (dollars in thousands): Nine Months endedNovember 30, 2020 Total YTD Change in Unrealized Unrealized Appreciation Appreciation
Issuer Asset Type Cost Fair Value (Depreciation) (Depreciation) Knowland Group, Second Lien Term Loan LLC$ 15,768 $ 12,118 $ (3,650 ) $ (3,544 ) C2 Educational First Lien Term Loan Systems 15,993 12,987 (3,006 ) (3,024 ) ArbiterSports, First Lien Term Loan LLC 26,793 24,521 (2,272 ) (2,246 ) Roscoe Medical, Second Lien Term Loan & Inc. Equity Interests 4,708 4,338 (370 ) 2,201 My Alarm Center, Equity Interests LLC 4,867 306 (4,561 ) (1,691 ) Elyria Foundry Second Lien Term Loan & Company, L.L.C. Equity Interests 11,019 1,998
(9,021 ) (1,276 ) The net changes in unrealized depreciation for the nine months endedNovember 30, 2020 noted above primarily relate to the impact of COVID-19, resulting in changes to market spreads, EBITDA multiples and/or revised portfolio company performance, following the events sinceMarch 2020 . The most significant cumulative net change in unrealized appreciation for the nine months endedNovember 30, 2019 were the following (dollars in thousands): Nine Months ended November 30, 2019 Total YTD Change in Unrealized Unrealized Issuer Asset Type Cost Fair Value Appreciation Appreciation Easy Ice, LLC Second Term Lien Loan & Equity Interests$ 37,822 $ 47,316 $ 9,494 $ 5,626 Saratoga Structured Finance Investment Corp. Securities CLO 2013-1, Ltd. 24,268 24,497 229 (1,648 ) 82
The$5.6 million net change in unrealized appreciation in our investment inEasy Ice, LLC was driven by a continued increase in the scale and earnings of the business.
The
Changes in net assets resulting from operations
For the three months endedNovember 30, 2020 , we recorded a net increase in net assets resulting from operations of$6.4 million . Based on 11,169,817 weighted average common shares outstanding as ofNovember 30, 2020 , our per share net increase in net assets resulting from operations was$0.57 for the three months endedNovember 30, 2020 . For the three months endedNovember 30, 2019 , we recorded a net increase in net assets resulting from operations of$13.7 million , or$1.37 per share based on 10,036,086 weighted average common shares outstanding as ofNovember 30, 2019 . For the nine months endedNovember 30, 2020 , we recorded a net increase in net assets resulting from operations of$5.5 million . Based on 11,198,287 weighted average common shares outstanding as ofNovember 30, 2020 , our per share net increase in net assets resulting from operations was$0.49 for the nine months endedNovember 30, 2020 . For the nine months endedNovember 30, 2019 , we recorded a net increase in net assets resulting from operations of$28.9 million , or$3.33 per share based on 8,702,190 weighted average common shares outstanding as ofNovember 30, 2019 .
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash inU.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities. Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan ("DRIP"), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and theTreasury regulations and a revenue procedure issued by the Internal Revenue Service ("IRS"), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement. Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200.0%, reduced to 150.0% effectiveApril 16, 2019 following the approval received from the non-interested board of directors onApril 16, 2018 . This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 377.3% as ofNovember 30, 2020 and 607.1% as ofFebruary 29, 2020 . To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms,
if at all. Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value. 83
Madison revolving credit facility
Below is a summary of the terms of the senior secured revolving credit facility we entered into withMadison Capital Funding LLC (the "Credit Facility") onJune 30, 2010 , which was most recently amended onSeptember 14, 2020 . (See Recent Developments). Availability. The Company can draw up to the lesser of (i)$40.0 million (the "Facility Amount") and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the "Adjusted Borrowing Value"), of certain "eligible" loan assets pledged as security for the loan (the "Borrowing Base"), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the "Unfunded Exposure Amount") and outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset. The Credit Facility contains limitations on the type of loan assets that are "eligible" to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an "eligible" loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders. Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes ("CLO Notes") issued by Saratoga CLO and the Company's rights under the CLO Management Agreement (as defined below). Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company's option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility. Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the "Revolving Period"). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period. Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the "Borrowing Base Test"). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the "Collateral Tests"):
? Interest Coverage Ratio. The ratio (expressed as a percentage) of interest
collections with respect to pledged loan assets, less certain fees and expenses
relating to the Credit Facility, to accrued interest and commitment fees and
any breakage costs payable to the lenders under the Credit Facility for the
last 6 payment periods must equal at least 175.0%.
? Overcollateralization Ratio. The ratio (expressed as a percentage) of the
aggregate Adjusted Borrowing Value of "eligible" pledged loan assets plus the
fair value of certain ineligible pledged loan assets and the CLO Notes (in each
case, subject to certain adjustments) to outstanding borrowings under the
Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.
? Weighted Average FMV Test. The aggregate adjusted or weighted value of
"eligible" pledged loan assets as a percentage of the aggregate outstanding
principal balance of "eligible" pledged loan assets must be equal to or greater
than 72.0% and 80.0% during the one-year periods prior to the first and second
anniversary of the closing date, respectively, and 85.0% at all times thereafter. The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company's breach of its representation and warranty that pledged loan assets included in the Borrowing Base are "eligible" loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.
84
Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date. Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of "eligible" pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of "eligible" pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders. Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the "Unfunded Exposure Account") 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above. Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to$350,000 for each monthly payment date or$2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company's assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision. Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:
? an Interest Coverage Ratio of less than 150.0%;
? an Overcollateralization Ratio of less than 175.0%;
? the filing of certain ERISA or tax liens;
? the occurrence of certain "Manager Events" such as:
? failure by
collectively, directly or indirectly, a cash equity investment in the Company
in an amount equal to at least
anniversary of the closing date;
? failure of the Management Agreement between
the Company to be in full force and effect;
? indictment or conviction of
for a felony offense, or any fraud, embezzlement or misappropriation of funds
by
persons," without a reputable, experienced individual reasonably satisfactory
to
85
? resignation, termination, disability or death of a "key person" or failure of
any "key person" to provide active participation in
Advisors' daily activities, all without a reputable, experienced individual
reasonably satisfactory to
? occurrence of any event constituting "cause" under the Collateral Management
Agreement between the Company and Saratoga CLO (the "CLO Management
Agreement"), delivery of a notice under Section 12(c) of the CLO Management
Agreement with respect to the removal of the Company as collateral manager or
the Company ceases to act as collateral manager under the CLO Management Agreement.
Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction withSaratoga Investment Advisors' policies, personnel and processes relating to the loan assets. Fees and Expenses. The Company paid certain fees and reimbursedMadison Capital Funding LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred byMadison Capital Funding LLC in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction withSaratoga Investment Advisors and certain of its affiliates. These amounts totaled$2.0 million .
On
? expand the borrowing capacity under the Credit Facility from
$45.0 million ;
? extend the period during which we may make and repay borrowings under the
Credit Facility from
Period"). The Revolving Period may, upon the occurrence of an event of default,
by action of the lenders or automatically, be terminated. All borrowings and
other amounts payable under the Credit Facility are due and payable five years
after the end of the Revolving Period; and
? remove the condition that we may not acquire additional loan assets without the
prior written consent of the administrative agent.
On
? extend the commitment termination date from
2017;
? extend the maturity date of the Revolving Facility from
? reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%,
and on LIBOR borrowings from 5.50% to 4.75%; and
? reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR
borrowings from 2.00% to 1.25%.
On
? extend the commitment termination date from
2020;
? extend the final maturity date of the Credit Facility from
toSeptember 17, 2025 ;
? reduce the floor on base rate borrowings from 2.25% to 2.00%;
? reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and
? reduce the commitment fee rate from 0.75% to 0.50% for any period during which
the ratio of advances outstanding to aggregate commitments, expressed as a
percentage, is greater than or equal to 50%.
On
? permit certain amendments related to the Paycheck Protection Program
("Permitted PPP Amendment") to Loan Asset Documents;
86
? exclude certain debt and interest amounts allowed by the Permitted PPP
Amendments from certain calculations related to Net Leverage Ratio, Interest
Coverage Ratio and EBITDA; and
? exclude such Permitted PPP Amendments from constituting a Material
Modification.
On
? extend the commitment termination date of the Credit Facility from September
17, 2020 to
September 17, 2025 .
? provide for the transition away from the LIBOR Rate in the market, and
? expand the definition of "Eligible Loan Asset" to allow investments with
certain recurring revenue features to qualify as Collateral and be included in
the borrowing base.
As ofNovember 30, 2020 , we had no outstanding borrowings under the Credit Facility and$176.0 million of SBA-guaranteed debentures outstanding (which are discussed below). As ofFebruary 29, 2020 , we had no outstanding borrowings under the Credit Facility and$150.0 million of SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility atNovember 30, 2020 andFebruary 29, 2020 was$46.4 million and$35.6 million , respectively.
Our asset coverage ratio, as defined in the 1940 Act, was 377.3% as of
SBA-guaranteed debentures
In addition, we, through two wholly-owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, onMarch 28, 2012 , our wholly-owned subsidiary,Saratoga Investment Corp. SBIC LP , received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958 and onAugust 14, 2019 , our wholly-owned subsidiary,Saratoga Investment Corp. SBIC II LP , also received a license. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. The SBIC licenses allows our SBIC subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread overU.S. Treasury Notes with 10-year maturities. SBA regulations previously limited the amount that our SBIC subsidiary may borrow to a maximum of$150.0 million when it has at least$75.0 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. This maximum has been increased by SBA regulators for new licenses to$175.0 million of SBA debentures when it has at least$87.5 million in regulatory capital. The new license will provide up to$175.0 million in additional long-term capital in the form of SBA-guaranteed debentures.The SBIC LP andSBIC II LP are regulated by the SBA. As a result of the 2016 omnibus spending bill signed into law inDecember 2015 , the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from$225.0 million to$350.0 million . Our wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. With this license approval, Saratoga can grow its SBA relationship from$150.0 million to$325.0 million of committed capital. We received exemptive relief from theSEC to permit us to exclude the debt of our SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to$325.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. OnApril 16, 2018 , as permitted by the Small Business Credit Availability Act, which was signed into law onMarch 23, 2018 , our non-interested board of directors approved of our becoming subject to a minimum asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150.0% asset coverage ratio became effective onApril 16, 2019 . As ofNovember 30, 2020 , ourSBIC LP subsidiary had$75.0 million in regulatory capital and$150.0 million in SBA-guaranteed debentures outstanding and ourSBIC II LP subsidiary had$69.0 million in regulatory capital and$26.0 million in SBA-guaranteed debentures outstanding. 87 Unsecured notes
InMay 2013 , the Company issued$48.3 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the "2020 Notes"). The 2020 Notes were redeemed in full onJanuary 13, 2017 and are no longer listed on the NYSE. OnMay 29, 2015 , we entered into a Debt Distribution Agreement withLadenburg Thalmann & Co. through which we may offer for sale, from time to time, up to$20.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 bonds with a principal of$13.5 million at an average price of$25.31 for aggregate net proceeds of$13.4 million (net of transaction costs). OnDecember 21, 2016 , we issued$74.5 million in aggregate principal amount of our 2023 Notes for net proceeds of$71.7 million after deducting underwriting commissions of approximately$2.3 million and offering costs of approximately$0.5 million . The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes onJanuary 13, 2017 , which amounted to$61.8 million , and for general corporate purposes in accordance with our investment objective and strategies. OnDecember 21, 2019 andFebruary 7, 2020 , the Company redeemed$50.0 million and$24.5 million , respectively, in aggregate principal amount of the$74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE. OnAugust 28, 2018 , the Company issued$40.0 million in aggregate principal amount of our 6.25% fixed-rate notes due 2025 (the "6.25% 2025 Notes") for net proceeds of$38.7 million after deducting underwriting commissions of approximately$1.3 million . Offering costs incurred were approximately$0.3 million . The issuance included the full exercise of the underwriters' option to purchase an additional$5.0 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 6.25% per year, beginningNovember 30, 2018 . The 6.25% 2025 Notes mature onAugust 31, 2025 and commencingAugust 28, 2021 , may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$1.6 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol "SAF" with a par value of$25.00 per share. OnFebruary 5, 2019 , the Company completed a re-opening and up-sizing of its existing 6.25% 2025 Notes by issuing an additional$20.0 million in aggregate principal amount for net proceeds of$19.2 million after deducting underwriting commissions of approximately$0.6 million and discount of$0.2 million . Offering costs incurred were approximately$0.2 million . The issuance included the full exercise of the underwriters' option to purchase an additional$2.5 million aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate, interest payment dates and maturity remain unchanged from the existing 6.25% 2025 Notes issued inAugust 2018 . The net proceeds from this offering were used for general corporate purposes in accordance with our investment objective and strategies. The financing costs and discount of$1.0 million related to the 6.25% 2025 Notes have been capitalized and are being amortized over the term of the 6.25% 2025 Notes.
At
In connection with the issuance of the 6.25% 2025 Notes, we agreed to the following covenants for the period of time during which the notes are outstanding:
? we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as
modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but
giving effect to any exemptive relief granted to us by the
provisions generally prohibit us from making additional borrowings, including
through the issuance of additional debt or the sale of additional debt
securities, unless our asset coverage, as defined in the 1940 Act, equals at
least 200% after such borrowings, or, if we obtain the required approvals from
our independent directors and/or stockholders, 150% (after deducting the amount
of such dividend, distribution or purchase price, as the case may be).
? we will not declare any dividend (except a dividend payable in our stock), or
declare any other distribution, upon a class of our capital stock, or purchase
any such capital stock, unless, in every such case, at the time of the
declaration of any such dividend or distribution, or at the time of any such
purchase, we have an asset coverage (as defined in the 1940 Act) of at least
150.0%, as such obligation may be amended or superseded, after deducting the
amount of such dividend, distribution or purchase price, as the case may be,
and in each case giving effect to (i) any exemptive relief granted to us by the
us if we determine to seek such similar no-action or other relief) permitting
the BDC to declare any cash dividend or distribution notwithstanding the
prohibition contained in Section 18(a)(1)(B) as modified by such provisions of
Section 61(a) of the 1940 Act as may be applicable to us from time to time, as
such obligation may be amended or superseded, in order to maintain such BDC's
status as a regulated investment company under Subchapter M of the Code.
88
? if, at any time, we are not subject to the reporting requirements of Sections
13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to
file any periodic reports with the
6.25% 2025 Notes and the Trustee, for the period of time during which the 6.25%
2025 Notes are outstanding, our audited annual consolidated financial
statements, within 90 days of our fiscal year end, and unaudited interim
consolidated financial statements, within 45 days of our fiscal quarter end
(other than our fourth fiscal quarter). All such financial statements will be
prepared, in all material respects, in accordance with applicable
generally accepted accounting principles. OnJune 24, 2020 , the Company issued$37.5 million in aggregate principal amount of our 7.25% fixed-rate notes due 2025 (the "7.25% 2025 Notes") for net proceeds of$36.3 million after deducting underwriting commissions of approximately$1.2 million . Offering costs incurred were approximately$0.3 million . OnJuly 6, 2020 , the underwriters exercised their option in full to purchase an additional$5.625 million in aggregate principal amount of its 7.25% unsecured notes due 2025. Net proceeds to the Company were$5.4 million after deducting underwriting commissions of approximately$0.2 million . Interest on the 7.25% 2025 Notes is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 7.25% per year, beginningAugust 31, 2020 . The 7.25% 2025 Notes mature onJune 30, 2025 and commencingJune 24, 2022 , may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$1.6 million related to the 7.25% 2025 Notes have been capitalized and are being amortized over the term of the 7.25% 2025 Notes. The Company has received an investment grade private rating of "BBB" fromEgan-Jones Ratings Company , an independent, unaffiliated rating agency. The 7.25% 2025 Notes are listed on the NYSE under the trading symbol "SAK" with a par value of$25.00 per share. AtNovember 30, 2020 , the total 7.25% 2025 Notes outstanding was$43.1 million . OnJuly 9, 2020 , the Company issued$5.0 million aggregate principal amount of our 7.75% fixed-rate Notes due in 2025 (the "7.75% 2025 Notes") for net proceeds of$4.8 million after deducting underwriting commissions of approximately$0.2 million . Offering costs incurred were approximately$0.1 million . Interest on the 7.75% Notes 2025 is paid quarterly in arrears onFebruary 28 ,May 31 ,August 31 andNovember 30 , at a rate of 7.75% per year, beginningAugust 31, 2020 . The 7.75% Notes 2025 mature onJuly 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of$0.3 million related to the 7.75% Notes 2025 have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are unlisted and have a par value of$25.00 per share.
At
OnJuly 13, 2018 , the Company issued 1,150,000 shares of its common stock priced at$25.00 per share (par value$0.001 per share) at an aggregate total of$28.75 million . The net proceeds, after deducting underwriting commissions of$1.15 million and offering costs of approximately$0.2 million , amounted to approximately$27.4 million . The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock,
which was not exercised.
AtNovember 30, 2020 andFebruary 29, 2020 , the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows: November 30, 2020 February 29, 2020 Percentage Percentage Fair Value of Total Fair Value of Total ($ in
thousands)
Cash and cash equivalents$ 21,060 3.6 %$ 24,599 4.7 % Cash and cash equivalents, reserve accounts 12,837 2.3
14,851 2.8 First lien term loans 407,698 70.1 346,233 66.0 Second lien term loans 50,027 8.6 73,570 14.0 Unsecured term loans 26,817 4.6 4,346 0.8
Structured finance securities 31,299 5.4
32,470 6.2 Equity interests 31,102 5.4 29,013 5.5 Total$ 580,840 100.0 %$ 525,082 100.0 % 89 OnMarch 16, 2017 , we entered into an equity distribution agreement withLadenburg Thalmann & Co. Inc. , through which we may offer for sale, from time to time, up to$30.0 million of our common stock through an ATM offering. Subsequent to this,BB&T Capital Markets andB. Riley FBR, Inc. were also added to the agreement. OnJuly 11, 2019 , the amount of the common stock to be offered through this offering was increased to$70.0 million , and onOctober 8, 2019 , the amount of the common stock to be offered was increased to$130.0 million . As ofNovember 30, 2020 , the Company sold 3,922,018 shares for gross proceeds of$97.1 million at an average price of$24.77 for aggregate net proceeds of$95.9 million (net of transaction costs). During the nine months endedNovember 30, 2020 , there was no activity related to the ATM offering. OnSeptember 24, 2014 , the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the "Share Repurchase Plan"). OnOctober 7, 2015 , our board of directors extended the Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. OnOctober 5, 2016 , our board of directors extended the Share Repurchase Plan for another year toOctober 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. OnOctober 10, 2017 ,January 8, 2019 andJanuary 7, 2020 , our board of directors extended the Share Repurchase Plan for another year toOctober 15, 2018 ,January 15, 2020 andJanuary 15, 2021 , respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. OnMay 4, 2020 , our board of directors increased the Share Repurchase Plan to 1.3 million shares of common stock. OnJanuary 5, 2021 , our board of directors extended the Share Repurchase Plan for another year toJanuary 15, 2022 , leaving the number of shares unchanged at 1.3 million shares of common stock. As ofNovember 30, 2020 , the Company purchased 358,812 shares of common stock, at the average price of$17.14 for approximately$6.2 million pursuant to the Share Repurchase Plan. During the three months endedNovember 30, 2020 , the Company purchased 50,000 shares of common stock, at the average price of$18.28 for approximately$0.9 million pursuant to the Share Repurchase Plan. During the nine months endedNovember 30, 2020 , the Company purchased 140,321 shares of common stock, at the average price of$17.56 for approximately$2.5 million pursuant to the Share Repurchase Plan. OnOctober 7, 2020 , our board of directors declared a dividend of$0.41 per share, which was paid onNovember 10, 2020 , to common stockholders of record as ofOctober 26, 2020 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onOctober 28 , 29, 30 andNovember 2 , 3, 4, 5, 6, 9 and 10, 2020.
OnJuly 7, 2020 , the Company declared a dividend of$0.40 per share payable onAugust 12, 2020 , to common stockholders of record onJuly 27, 2020 . Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately$3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onJuly 30 , 31 andAugust 3 , 4, 5, 6, 7, 10, 11 and 12, 2020. OnJanuary 7, 2020 , the Company declared a dividend of$0.56 per share, which was paid onFebruary 6, 2020 , to common stockholders of record onJanuary 24, 2020 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately$5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onJanuary 24 , 27, 28, 29, 30, 31 andFebruary 3 ,
4, 5 and 6, 2020. OnAugust 27, 2019 , the Company declared a dividend of$0.56 per share, which was paid onSeptember 26, 2019 , to common stockholders of record onSeptember 13, 2019 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately$4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onSeptember 13, 16 , 17, 18, 19, 20, 23, 24, 25 and 26, 2019. OnMay 28, 2019 , our board of directors declared a dividend of$0.55 per share, which was paid onJune 27, 2019 , to common stockholders of record as ofJune 13, 2019 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$22.65 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onJune 14, 17 , 18, 19, 20, 21, 24, 25, 26 and 27, 2019. 90 OnFebruary 26, 2019 , our board of directors declared a dividend of$0.54 per share, which was paid onMarch 28, 2019 , to common stockholders of record as ofMarch 14, 2019 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$21.36 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onMarch 15, 18 , 19, 20, 21, 22, 25, 26, 27 and 28, 2019. OnNovember 27, 2018 , our board of directors declared a dividend of$0.53 per share, which was paid onJanuary 2, 2019 , to common stockholders of record onDecember 17, 2018 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the Company's DRIP. Based on shareholder elections, the dividend consisted of approximately$3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onDecember 18, 19 , 20, 21, 24, 26, 27, 28, 31, 2018 andJanuary 2, 2019 . OnAugust 28, 2018 , our board of directors declared a dividend of$0.52 per share, which was paid onSeptember 27, 2018 , to common stockholders of record as ofSeptember 17, 2018 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onSeptember 14, 17 , 18, 19, 20, 21, 24, 25, 26 and 27, 2018. OnMay 30, 2018 , our board of directors declared a dividend of$0.51 per share, which was paid onJune 27, 2018 , to common stockholders of record as ofJune 15, 2018 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock onJune 14, 15 , 18, 19, 20, 21, 22, 25, 26 and 27, 2018. OnFebruary 26, 2018 , our board of directors declared a dividend of$0.50 per share, which was paid onMarch 26, 2018 , to common stockholders of record as ofMarch 14, 2018 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$19.91 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onMarch 13, 14 , 15, 16, 19, 20, 21, 22, 23 and 26, 2018. OnNovember 29, 2017 , our board of directors declared a dividend of$0.49 per share, which was paid onDecember 27, 2017 , to common stockholders of record onDecember 15, 2017 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$21.14 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onDecember 13, 14 , 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
OnAugust 28, 2017 , our board of directors declared a dividend of$0.48 per share, which was paid onSeptember 26, 2017 , to common stockholders of record onSeptember 15, 2017 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$20.19 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onSeptember 13, 14 , 15, 18, 19, 20, 21, 22,
25 and 26, 2017. OnMay 30, 2017 , our board of directors declared a dividend of$0.47 per share, which was paid onJune 27, 2017 , to common stockholders of record onJune 15, 2017 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$20.04 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onJune 14, 15 , 16, 19, 20, 21, 22, 23, 26 and 27, 2017. 91 OnFebruary 28, 2017 , our board of directors declared a dividend of$0.46 per share, which was paid onMarch 28, 2017 , to common stockholders of record as ofMarch 15, 2017 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$21.38 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onMarch 15, 16 , 17, 20, 21, 22, 23, 24, 27 and 28, 2017. OnJanuary 12, 2017 , our board of directors declared a dividend of$0.45 per share, which was paid onFebruary 9, 2017 , to common stockholders of record as ofJanuary 31, 2017 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$20.25 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onJanuary 27 , 30, 31 andFebruary 1 , 2, 3, 6, 7, 8 and 9, 2017.
OnOctober 5, 2016 , our board of directors declared a dividend of$0.44 per share, which was paid onNovember 9, 2016 , to common stockholders of record as ofOctober 31, 2016 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$17.12 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onOctober 27 , 28, 31 andNovember 1 , 2, 3, 4, 7, 8 and 9, 2016. OnAugust 8, 2016 , our board of directors declared a special dividend of$0.20 per share, which was paid onSeptember 5, 2016 , to common stockholders of record as ofAugust 24, 2016 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$17.06 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onAugust 22 , 23, 24, 25, 26, 29, 30, 31 andSeptember 1 and 2, 2016. OnJuly 7, 2016 , our board of directors declared a dividend of$0.43 per share, which was paid onAugust 9, 2016 , to common stockholders of record as ofJuly 29, 2016 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$16.32 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onJuly 27 , 28, 29 andAugust 1 , 2, 3, 4, 5, 8 and 9, 2016. OnMarch 31, 2016 , our board of directors declared a dividend of$0.41 per share, which was paid onApril 27, 2016 , to common stockholders of record as ofApril 15, 2016 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$15.43 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onApril 14, 15 , 18, 19, 20, 21, 22, 25, 26 and 27, 2016. OnJanuary 12, 2016 , our board of directors declared a dividend of$0.40 per share, which was paid onFebruary 29, 2016 , to common stockholders of record as ofFebruary 1, 2016 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$13.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onFebruary 16, 17 , 18, 19, 22, 23, 24, 25, 26 and 29, 2016.
OnOctober 7, 2015 , our board of directors declared a dividend of$0.36 per share, which was paid onNovember 30, 2015 , to common stockholders of record as ofNovember 2, 2015 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$14.53 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onNovember 16, 17 , 18, 19, 20, 23, 24, 25, 27 and 30, 2015. 92 OnJuly 8, 2015 , our board of directors declared a dividend of$0.33 per share, which was paid onAugust 31, 2015 , to common stockholders of record as ofAugust 3, 2015 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$15.28 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onAugust 18, 19 , 20, 21, 24, 25, 26, 27, 28 and 31, 2015. OnMay 14, 2015 , our board of directors declared a special dividend of$1.00 per share, which was paid onJune 5, 2015 , to common stockholders of record on as ofMay 26, 2015 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$16.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onMay 22 , 26, 27, 28, 29 andJune 1 , 2, 3, 4 and 5, 2015. OnApril 9, 2015 , our board of directors declared a dividend of$0.27 per share, which was paid onMay 29, 2015 , to common stockholders of record as ofMay 4, 2015 . Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$16.78 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onMay 15, 18 , 19, 20, 21, 22, 26, 27, 28 and 29, 2015. OnSeptember 24, 2014 , our board of directors declared a dividend of$0.22 per share, which was paid onFebruary 27, 2015 , to common stockholders of record onFebruary 2, 2015 . Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$14.97 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onFebruary 13, 17 , 18, 19, 20, 23, 24, 25, 26 and 27, 2015.
Also, onSeptember 24, 2014 , our board of directors declared a dividend of$0.18 per share, which was paid onNovember 28, 2014 , to common stockholders of record onNovember 3, 2014 . Shareholders had the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the DRIP. Based on shareholder elections, the dividend consisted of approximately$0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of$14.37 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onNovember 14, 17 , 18, 19, 20, 21, 24, 25, 26 and 28, 2014. OnOctober 30, 2013 , our board of directors declared a dividend of$2.65 per share, which was paid onDecember 27, 2013 , to common stockholders of record as ofNovember 13, 2013 . Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately$2.5 million or$0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by theIRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. Based on shareholder elections, the dividend consisted of approximately$2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of$15.439 per share, which 95% of equaled the volume weighted average trading price per share of the common stock onDecember 11, 13 , and 16, 2013. OnNovember 9, 2012 , our board of directors declared a dividend of$4.25 per share, which was paid onDecember 31, 2012 , to common stockholders of record as ofNovember 20, 2012 . Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately$3.3 million or$0.85 per share. Based on shareholder elections, the dividend consisted of$3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of$15.444 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onDecember 14, 17 and
19, 2012. 93 OnNovember 15, 2011 , our board of directors declared a dividend of$3.00 per share, which was paid onDecember 30, 2011 , to common stockholders of record as ofNovember 25, 2011 . Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to$2.0 million or$0.60 per share. Based on shareholder elections, the dividend consisted of$2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of$13.117067 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onDecember 20 , 21 and 22, 2011. OnNovember 12, 2010 , our board of directors declared a dividend of$4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of theIRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid onDecember 29, 2010 to common shareholders of record onNovember 19, 2010 . Based on shareholder elections, the dividend consisted of$1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of$17.8049 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onDecember 20 , 21 and 22, 2010. OnNovember 13, 2009 , our board of directors declared a dividend of$18.25 per share, which was paid onDecember 31, 2009 , to common stockholders of record as ofNovember 25, 2009 . Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to$2.1 million or$0.25 per share. Based on shareholder elections, the dividend consisted of$2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of$1.5099 per share, which equaled 95% of the volume weighted average trading price per share of the common stock onDecember 24 and 28, 2009.
We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.
Contractual obligations
The following table shows our payment obligations for repayment of debt and
other contractual obligations at
Payment Due by Period Less Than 1 - 3 3 - 5 More Than
Long-Term Debt Obligations Total 1 Year Years
Years 5 Years
($ in thousands) Revolving credit facility $ - $ - $ - $ - $ - SBA debentures 176,000 - 40,000 39,000 97,000 6.25% 2025 Notes 60,000 - - 60,000 - 7.25% 2025 Notes 43,125 - - 43,125 - 7.75% 2025 Notes 5,000 - 5,000 - Total Long-Term Debt Obligations$ 284,125 $ -$ 40,000 $ 147,125 $ 97,000 94
Off-balance sheet arrangements
As ofNovember 30, 2020 andFebruary 29, 2020 , the Company's off-balance sheet arrangements consisted of$49.8 million and$64.1 million , respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company's discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company's consolidated statements of assets and liabilities and are not reflected in the Company's consolidated statements of assets and liabilities.
A summary of the unfunded commitments outstanding as of
November 30, February 29, 2020 2020At Company's discretion CLEO Communications Holding, LLC $ 630 $ - inMotionNow, Inc. - 3,000 Omatic Software, LLC - 1,000 Passageways, Inc. 5,000 5,000 PDDS Buyer, LLC - 5,000
Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. - 17,500 Top Gun Pressure Washing, LLC 3,175 5,000 Village Realty Holdings LLC 10,000 10,000 18,805 46,500 At portfolio company's discretion - satisfaction of certain financial and nonfinancial covenants required ArbiterSports, LLC - 1,000 Axiom Purchaser, Inc. - 1,000 CoConstruct, LLC 6,500 3,500 Davisware, LLC 1,022 2,000 GoReact 2,000 2,000 Granite Comfort, LP 8,000 - HemaTerra Holding Company, LLC 2,000 4,000 New England Dental Partners 7,445 - Passageways, Inc. 3,000 3,000 Procurement Partners, LLC 1,000 - Village Realty Holdings LLC - 1,124 30,967 17,624 Total$ 49,772 $ 64,124 Recent Developments
On
Subsequent toNovember 30, 2020 , the global outbreak of the COVID-19 pandemic has adversely affected some of the Company's investments and continues to have adverse consequences on theU.S. and global economies. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual portfolio companies, remains uncertain. At the time of this filing, there is no indication of a reportable subsequent event impacting the Company's financial statements for the quarter endedNovember 30, 2020 . The Company cannot predict the extent to which its financial condition and results of operations will be adversely affected at this time. The potential impact to our results will depend to a large extent on future developments and new information that may emerge regarding the duration and severity of COVID-19. The Company continues to observe and respond to the evolving COVID-19 environment and its potential impact on areas across its business. 95
© Edgar Online, source